INTRODUCTION
Chronic bile duct ligation (BDL) induces intense changes in the circulatory and renal function such as a fall in blood pressure and sodium retention, leading to the development of ascites and the hepatorenal syndrome with the advance of the disease (21, 24) At this point, the therapeutic options are complicated and very limited. Recently, several investigations have been proposed to examine whether oxidative stress is implicated in those alterations, so that more effective therapeutic tools could be developed. This is due to the fact that oxidative stress levels are increased in plasma and urine from patients and rats with liver disease (10, 31, (37) (38) and can reach extremely high concentrations in patients with hepatorenal syndrome (34, 36) , a condition characterized by profound renal sodium and water retention. Moreover, antioxidants may delay the development of a hyperdynamic circulatory state during experimental cirrhosis (17, 32) and improve renal dysfunction (1, 25, 41) . However, it is unknown whether antioxidants can also prevent the altered systemic and renal vascular reactivity induced by liver cirrhosis.
Oxidative stress involves the generation of reactive oxygen species (ROS; O 2 .-5 Rats were randomized into three groups: 1) untreated control rats (Control group; n = 19);
2) untreated BDL rats (BDL group; n = 24); and 3) BDL rats treated with vitamin E (BDL+VitE group; n = 22). A time control group of rats treated with vitamin E (Sham+VitE group; n = 4) was also included in the study. Both untreated groups were maintained on standard rat chow containing a normal essential amount of vitamin E (50 IU/Kg diet). Group 3 received a diet supplemented with vitamin E (5000 IU/Kg diet, dry vitamin E acetate; Panlab S.L., Barcelona, Spain) starting one week prior to surgery (day 0). All the rats were acclimated to individual metabolic cages in order to collect 24 hour-urine samples, to determine urinary nitrites excretion. These were obtained during 2 consecutive days before surgery (days -2 and -1) and 2 days just before the experimental day (days 20 and 21 after surgery).
Experimental procedure.
Preparation of isolated perfused kidneys and functional procedures.
The rats were anesthetized and placed on a heated table to maintain body temperature at 37 o C. A polyethylene cannula (PE-50) was placed in the right femoral artery for blood collection and for measuring blood pressure. Subsequently, we proceeded to isolate and perfuse the kidney as described previously (19) . Briefly, the left kidney was exposed by a midline laparotomy and the renal artery cannulated via suprarenal aorta to prevent or minimize interruption of blood flow. The kidney was perfused in situ with warm oxygenated Krebs' buffer (mM, NaCl, 118; KCl, 4.7; CaCl 2 , 2.5; MgSO 4 , 1.2; NaHCO 3 , 25; KH 2 PO 4 , 1.2; edetate calcium disodium, 0.026; and glucose, 5.6, pH 7.4) at 37° C, blood free and at a constant rate of 5 ml/min/g kidney weight with a peristaltic pump (Master-flex 7518-00, Coler-Parmer Instrument Company, Niles, Illinois). The left renal vein was then cut and the ureter transected to allow exit of the perfusate. Finally, the kidney was excised from the surrounding tissues, decapsulated (to minimize any influence of interstitial pressure changes on renal vascular responses) and placed in a chamber containing Krebs solution at 37º C 6 and the perfusate lost from the renal vein, both continuously drawn out of the chamber at the same rate of perfusion. Renal vascular responses were recorded through a transducer connected to a Macintosh LCII computer and analyzed with MacLab software (AD Instruments, UK) as changes in renal perfusion pressure (RPP) downstream from the pump. Then, the right kidney and the thoracic aorta were removed and frozen for later studies. The weight of the right kidney was used as an index of the left kidney weight and the spleen weight as a reference of portal hypertension presence.
Renal responses to Phenylephrine (PHE) and Acetylcholine (ACH).
After a 30-min stabilization period, we performed a dose-response curve to increasing doses of PHE (10 -7 , 5.10 -6 , 10 -6 , 5.10 -5 , 10 -5 , 5.10 -4 and 10 -4 M) administered as a 0.1 ml bolus. The approximate time between doses was 2 min, estimated time to reach the plateau with each dose, and similar to the required time to obtain a steady state response by using a continuous infusion. In a subset of rats from each group 1, 2 and 3, the experiment was performed in the presence of Nwnitro-L-arginine methyl ester (L-NAME, 10 -4 M) to inhibit NO synthesis. Thus, the drug was added to the krebs solution 30 min before the initiation of the PHE dose-response curve and maintained it during the rest of the experiment.
Following the PHE curve and after another 30-min stabilization period, the renal vasculature was preconstricted with PHE (10 -6 -10 -4 M) to reach a 75% of the maximal constriction observed in the previous curve. Once a stable elevated perfusion pressure was reached, the vasodilator responses to ACH (10 -8 to 10 -4 M) and to sodium nitroprusside (SNP; 10 -6 to 10 -4 M) were determined in all groups to assess NO and endothelium-dependent or -independent vasodilator responses, respectively. Changes in renal perfusion pressure (RPP) in response to vasodilators are expressed as a percentage of the vasoconstriction obtained with PHE.
Preparation of aortic rings and functional procedures.
A different set of animals was used for these experiments. After anesthesia, thoracic aortas 7 were dissected free and cut into 3 mm rings in warm Krebs solution. Aortic rings were placed in 10 ml-organ chambers to analyze vascular reactivity, as previously described (39) . After equilibration, a cumulative concentration-response curve for PHE (10 -8 to 10 -5 ) was obtained. After repeated washing, rings were again constricted at 75% of the PHE maximal contraction to perform the cumulative concentration-response curve to ACH (10 -8 to 10 -4 M). L-NAME (10 -4 M) was also used in a subgroup of rats from each group 1, 2 and 3. The presence of functional endothelium was confirmed after obtaining at least a 70% relaxation to ACH. In the L-NAME treated-rings, SNP (10 
Analytical measures.
Thiobarbituric acid reactive substances (TBARS) were determined in plasma and kidney tissue, as a measure of lipid peroxidation, by a colorimetric method used previously (41) . Urinary excretion of nitrites was determined by using the Griess reaction (40) in 24-hour urine samples.
Renal and aortic expression of phospho-ERK1/2.
Western blotting of aortas and kidneys were performed following standard procedures, as described (20). Frozen aortas and kidneys were homogenized in a lysis buffer containing 150 mM NaCl, 5 mM EDTA, 20 mM Tris-HCl, supplemented with detergents (0.5% Igepal CA-630 and 1%
Triton-X) and a cocktail of protease inhibitors (aprotinin 2µg/ml, Pepstatin A 1µg/ml, Leupeptin 10µg/ml, 500 µM Na 3 VO 4 and 1mM PMSF). The homogenate tissue was spun down (10 min, 20,000 rpm) at 4ºC, the pellet discarded and the supernatant kept as tissue lysate. The protein concentration was measured in the lysates using a bicinchoninic acid method (Sigma). Protein samples (50-100µg) were mixed (1:1) in 2x sample buffer (2% 2-Beta-Mercaptoethanol, 4% SDS, 
Histologic Analysis
Liver tissue samples were fixed in 10% buffered formaldehyde, and then processed and embedded in paraffin and sectioned (~5µm), as previously reported (15, 41) . These sections were then stained with hematoxylin and eosin, and viewed by light microscopy. A pathologist then 9 performed morphologic evaluation in blinded randomized sections of the liver tissue.
Statistical Methods.
Data are presented as means ± standard error of the mean (SEM). Differences between groups were compared by one-way repeated measures analysis of variance (ANOVA). For the doseresponse curves, we applied a two-way repeated measures analysis of variance, and when significantly different, means were further compared by the Neuman Keuls' test. The ED 50 (concentration of agonist producing 50% of the maximal response) is derived from logarithm transformation and regression analysis of each individual concentration response curves. Statistical significance was considered at a P level lower than 0.05.
RESULTS

General parameters.
BDL rats had significant lower body weight (244±11 vs 322±6 g) and hematocrit ( Untreated BDL rats had lower BP as compared to controls (84±3 vs 122±6 mmHg) and treatment with Vitamin E significantly increased it ( BDL+VitE, 100±6 mmHg, figure 1, top). Basal RPP was also lower in the BDL rats than in controls (37±3 vs 66±11 mmHg) and vitamin E normalized it (65±8, figure 1, bottom) . A similar pattern in basal RPP was observed in the L-10 NAME subgroup (BDL, 29±5; Control, 63±10; and BDL+VitE, 48±5 mmHg) in which not statistical differences were observed between groups after L-NAME administration (43±9; 72±13; and 73±12 mmHg, respectively). Chronic vitamin E administration did not modify either BP (115±4 mmHg) or RPP (54±4 mmHg) to the control rats.
Finally, histological analysis of all the BDL rat livers revealed an altered pattern of liver tissue structure as compared with the control groups with a marked bile-duct proliferation and patchy necrosis.
Renal vascular responses in the isolated and perfused kidneys.
The administration of PHE induced dose-dependent increases in RPP (figure 2, top) that were significantly reduced in the BDL rats and normalized by vitamin E supplementation (left panel). The ED50 value (table 1) was higher in the BDL group and also normalized by vitamin E. L-NAME administration (right panel) eliminated the differences between groups in response to PHE, and the BDL plus vitamin E group reached higher values than the untreated BDL as well as greater ED50 and maximal response values (table 1) .
The response to ACH (figure 2, bottom panels, and table 1) was reduced in the BDL kidneys and treatment with vitamin E restored it (left bottom panel and table 1). No differences were found between groups after L-NAME administration (right bottom panel). The ED50 values for ACH responses were similar in all groups (table 1). The Sham+VitE group showed a similar pattern of renal vascular responses to PHE and ACH than the control group, even though the PHE-ED50 value was a little different. SNP induced similar responses in all groups before and after L-NAME treatment.
Vascular Responses in aortic rings.
The response to PHE in aortic rings (figure 3, top panel and table 2) was significantly lower in BDL (treated or not with Vitamin E) than in controls and the addition of L -NAME to both BDL groups abolished the hyporesponsiveness to PHE. The ED50 value (table 2) was similar in control and BDL rings and lower in the BDL+VitE group. L-NAME significantly decreased ED50 in control and BDL rings. In contrast, ACH induced similar relaxations without differences between groups (except for BDL vs BDL+VitE) before or after L-NAME administration (figure 3, bottom panel). ED50 and maximal values of ACH responses remained unchanged in all groups (table 2) .
Both, ED50 values and the aortic vascular responses to PHE and ACH in the Sham+VitE group were comparable to the Control group (table 2) . Finally, treatments or manipulation did not alter smooth muscle function as SNP relaxed evenly and approximately 100 % all groups of rings.
Systemic and Renal Levels of ROS and NO (TBARS and 24 hr Urinary Nitrites).
Plasma levels of TBARS were increased in the BDL group and remained elevated after vitamin E supplementation ( figure 4, top) . Conversely, in the kidney tissue ( figure 4, middle) , vitamin E treatment decreased the elevated renal levels of TBARS in the BDL group . BDL rats had elevated 24-hr urinary nitrite excretion and administration of vitamin E further increased this value in BDL rats (figure 4, bottom).
Aorta and kidney protein expression of phospho-ERK1/2.
The aortic expression of pERK1/2 (figure 5, top panel) had a tendency to be greater in BDL groups although we did not find statistical differences between them. On the contrary, the renal expression of this protein (figure 5, bottom panel) was increased in the BDL group and vitamin E treatment returned the expression to control values.
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DISCUSSION.
The main findings in the present study are that vitamin E administration to BDL rats corrects the lower RPP and renal vascular responses to PHE and ACH. These effects were associated with a decrease in kidney TBARS and increased excretion of urinary nitrites, suggesting a better availability of NO in the renal vascular bed. We also found that the increased renal expression of pERK1/2 return to control values in the group of BDL treated with vitamin E. These results are consistent with our previous study in which we reported that vitamin E prevents renal dysfunction and improved hypotension induced by experimental BDL using in vivo anesthetized rats (41) and furthermore, brings to light additional mechanisms by which vitamin E may exert this beneficial effect.
Prolonged obstruction of the bile duct in the rat usually causes a cholestatic liver disease with hepatocellular damage and complicated by portal hypertension, ascites, and the presence of a hyperdynamic circulation that leads to progressive hypotension, renal dysfunction and death. The evolution is variable and the rats died usually within 5-8 weeks, depending on the strain used and even on the supplier (13, 15-16, 31-32, 41) . After 21 days of BDL (fourth week) the animals used in the present study showed typical signs of cirrhosis, such as decreased growth, jaundice and coluria, and a lower hematocrit. After death, the abdominal inspection revealed a little amount of ascites only in one or two rats of the BDL groups, but there was mesenteric edema as well as enlarged liver and spleen (indirect evidence of portal hypertension) in all of them. Morphologically the livers had marked ductal proliferation, fibrosis and patchy necrosis, and as we previously found (41) vitamin E treatment had small or no effect on the liver morphology, portal hypertension or spleen weight.
That is not entirely surprising since the vitamin E therapy is not addressing the primary insult, which is the surgical cholestasis. In addition, analyzing previous studies using different antioxidants that found a recovery in the systemic hemodynamic changes, we have observed that the 13 improvement in liver function is minimal (17, 32, 41). In fact, there was no improvement in serum bilirubin or albumin, and very minor decreases in plasma AST (Aspartate Aminotransferase) levels or portal pressures. Thus, we think that the data overall suggests that the antioxidant therapies employed in the present and past studies are not effective (or at best only marginally effective) in preventing the progression of the liver disease.
Chronic obstructive jaundice is also associated with severe hypotension and a predisposition to acute renal failure that may be related to changes in renovascular responsiveness (14, 27) . In this regard, reduced vascular responses to vasoconstrictors in different vascular beds have been reported in experimental models of portal hypertension with or without cirrhosis (3, 13, 19, 39) . In this study, we also found a lower renal vascular reactivity to phenylephrine in isolated kidneys from rats subjected to BDL compared to their controls. Moreover, basal RPP of the kidneys from BDL rats was also lower than in the control animals suggesting a basal dilatation of the renal vasculature of the BDL group. This decrease of basal RPP in the BDL kidneys can not be due to the systemic hypotension exhibited by BDL rats because first, the kidney was isolated from the animal and second, the perfusion rate was the same than in the control kidneys. Likely, this lower than normal renal vascular resistance, is due to intrarenal factors.
Nitric oxide, which is synthesized in excess during cirrhosis, has been one of the main implicated factors in this alteration. Thus, NO synthesis inhibition increased the reduced vascular responses in isolated kidneys (19) of rats with portal hypertension, as well as we found in the BDL model, indicating that elevated levels of NO is contributing to the renal vasodilation. In this regard, an interesting finding of our study is that the response to acetylcholine in the BDL kidneys was severely attenuated and inhibiting NO synthesis with L-NAME further blunted this response. These results suggested that a factor different to NO is affecting the kidney; alternatively, it is possible that the excess of NO or some NO-derived substance is being harmful to the endothelium relaxing function. In this way, Inan et al (27) obtained similar results and they suggested that the overproduction of NO may cause endothelial damage and/or desensitization of guanylate cyclase which in turn may result in loss of endothelium-dependent and -independent vasorelaxation. This is important because an altered renal endothelial vasodilatation may contribute to explain previous in vivo studies in cirrhotic animals showing a defective renal vascular and excretory response to maneuvers aimed at vasodilating the kidney (2, 4-5).
To further investigate this, we analyzed oxidative stress between other factors contributing to the altered vascular responses in cirrhosis. Oxidative stress is increased in patients and animals with cirrhosis and its levels correlate with the degree of the disease (10, 31, (36) (37) (38) . In addition, several studies have shown that antioxidants may prevent, correct, or improve the circulatory and renal anomalies in human (25) and experimental models of cirrhosis (1, 16-17, 32, 41) , although the mechanisms by which this occurs are not completely clarified. In this respect, we found that supplementation with vitamin E to BDL rats corrected the altered renal vascular reactivity to both phenylephrine and acetylcholine. To our knowledge, this is the first experimental evidence showing that an antioxidant improves renal vascular reactivity to both vasoconstrictors and vasodilators in rats with liver cirrhosis. This effect on renal vascular reactivity might contribute to explain part of the beneficial actions of antioxidants described in this and previous studies. The effect of vitamin E in the cirrhotic kidney appears to be dual. First, acting as a scavenger of ROS, as we found a significant decrease in kidney TBARS in the BDL-vitamin E treated animals ; and second, However, vitamin E treatment alone did not affect the aortic BDL hyporesponse and only after NOS inhibition the aortic response to phenylephrine was normalized in the cirrhotic rats and further increased if they were pre-treated with vitamin E. These responses in the aortic rings may be related to the different contribution of NO in the vascular responsiveness depending on the vascular bed studied (42, 46) as well as the different patterns of oxidative stress that may be found in different tissues (31, 38) . Actually, the levels of TBARS in kidney tissue are higher than in plasma, suggesting that kidneys are specially affected by oxidative stress and thus the effect of vitamin E supplementation is more pronounced in this tissue than systemically. In fact, during cirrhosis several substances able to induce oxidative stress are particularly elevated or affecting the kidney such as the renin-angiotensin system, endothelin and cathecolamines (21, 31). It is also possible that TBARS are not sensitive enough to detect the improvement although we found a similar behavior when measuring F 2 -isoprostanes (41), one of the more sensitive markers of oxidative stress (35) .
Thus, we think that it is more likely that there is compartmentalization of the antioxidant efficacy and renal oxidative stress may have been reduced without a reduction in the systemic. Furthermore, our results indicate that the BDL-induced changes in the vascular reactivity of the thoracic aorta are more dependent on NO, because only NOS inhibition normalized the response to phenylephrine in the cirrhotic rats, and it was under this condition that we saw some effect of vitamin E.
Finally, we found that expression of pERK1/2 is increased in kidney and aorta of BDL rats and administration of vitamin E normalized it in the kidney but not in aorta. These changes go in parallel with the results obtained in the vascular reactivity study and the oxidant stress markers, suggesting that they might be related. ERK1/2 is an extracellular regulated kinase sensitive to oxidative stress and can influence the contractile function (9, 26, 30, 44, 47) and promote growth and/or survival in vascular cells (22, 28) . An activation of ERK1/2 have been described in different models of hypertension and the degree related to the levels of blood pressure (47) and the mechanical stretch (26). Because our BDL rats have a reduced blood pressure and a systemic vasodilation, there is little probability that a blood pressure effect counts for the ERK1/2 activation and more probably be related to something common to these two diseases, a high oxidative stress.
Besides, during cirrhosis the activation of neurohumoral systems (angiotensin, endothelin, cathecolamines) induced by the hemodynamic changes can also contribute to a redox-sensitive phosphorilation of ERK1/2 (18). Thus, vitamin E would decrease ERK1/2 activation and restore vascular reactivity according to the improvement of oxidative stress markers which occurs in the kidney but not in aorta.
In addition, NO has been reported to activate the ERK1/2 pathway in VSMC and this activation seems to be involved in the inhibition of VSMC proliferation induced by NO (6, 23). But also a NO overproduction might be driven by oxidant stress via a phosphoinositide 3-kinase/Akt and MEK/ERK1/2 pathways (12, 43), which have been implicated in the endotoxin-induced vascular hyporeactivity (30) where NO and free radicals are greatly elevated. Then, during cirrhosis, the resulting disequilibrium between the unrestrained oxidative stress and NO, and their interactions, favor the activation of ERK1/2. Consequently, treating the cirrhotic animals with vitamin E restores the normal equilibrium, more clearly inside the kidney, contributing to normalize NO production and availability and thus the renal responses to phenylephrine and acetylcholine.
In conclusion, we have shown that vitamin E supplementation restores the abnormal renal vascular responses to phenylephrine and acetylcholine in BDL-induced cirrhotic rats. These effects were due to a decrease in oxidative stress-derived substances levels in the kidney and to a better availability of renal vascular NO. The changes in pERK1/2 expression suggest that this intracellular signaling pathway may be implicated in the contractile dysfunction of VSMC during chronic BDL, and can also contribute to explain part of the beneficial effects of vitamin E on renal vasculature. 
